Swedbank AB Increases Stock Position in Molina Healthcare, Inc $MOH

Swedbank AB grew its stake in shares of Molina Healthcare, Inc (NYSE:MOH) by 14.8% in the 4th quarter, Holdings Channel reports. The institutional investor owned 126,990 shares of the company’s stock after buying an additional 16,398 shares during the quarter. Swedbank AB’s holdings in Molina Healthcare were worth $22,038,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. Torren Management LLC purchased a new stake in shares of Molina Healthcare during the 4th quarter valued at $26,000. Miller Global Investments LLC purchased a new stake in shares of Molina Healthcare during the 4th quarter valued at $27,000. Cromwell Holdings LLC grew its stake in shares of Molina Healthcare by 211.9% during the 4th quarter. Cromwell Holdings LLC now owns 184 shares of the company’s stock valued at $32,000 after buying an additional 125 shares during the period. Rakuten Securities Inc. grew its stake in shares of Molina Healthcare by 5,020.0% during the 4th quarter. Rakuten Securities Inc. now owns 256 shares of the company’s stock valued at $44,000 after buying an additional 251 shares during the period. Finally, MUFG Securities EMEA plc purchased a new stake in shares of Molina Healthcare during the 2nd quarter valued at $48,000. 98.50% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Molina Healthcare news, CAO Maurice Hebert sold 600 shares of the business’s stock in a transaction on Thursday, May 14th. The shares were sold at an average price of $191.55, for a total value of $114,930.00. Following the transaction, the chief accounting officer owned 12,815 shares in the company, valued at $2,454,713.25. The trade was a 4.47% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Jeff D. Barlow sold 17,811 shares of the business’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the completion of the transaction, the insider owned 67,175 shares in the company, valued at $12,502,611. This represents a 20.96% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 1.44% of the company’s stock.

Molina Healthcare Stock Down 0.0%

Shares of Molina Healthcare stock opened at $184.08 on Tuesday. The company has a fifty day moving average price of $161.43 and a 200 day moving average price of $160.11. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.97. Molina Healthcare, Inc has a twelve month low of $121.06 and a twelve month high of $312.85. The stock has a market cap of $9.59 billion, a price-to-earnings ratio of 54.46 and a beta of 0.85.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings results on Wednesday, April 22nd. The company reported $2.35 earnings per share for the quarter, topping analysts’ consensus estimates of $1.57 by $0.78. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. The firm had revenue of $10.80 billion during the quarter, compared to analysts’ expectations of $10.91 billion. During the same period in the prior year, the company earned $6.08 EPS. The firm’s revenue was down 3.1% on a year-over-year basis. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. Equities research analysts forecast that Molina Healthcare, Inc will post 5.23 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several brokerages have recently issued reports on MOH. Truist Financial boosted their price objective on shares of Molina Healthcare from $180.00 to $205.00 and gave the company a “hold” rating in a research note on Monday, May 11th. The Goldman Sachs Group decreased their price target on shares of Molina Healthcare from $167.00 to $124.00 and set a “neutral” rating for the company in a research report on Wednesday, February 11th. Cantor Fitzgerald upped their price target on shares of Molina Healthcare from $144.00 to $209.00 and gave the stock a “neutral” rating in a research report on Monday, May 11th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a $129.00 price target on shares of Molina Healthcare in a research report on Friday, April 24th. Finally, Bank of America raised shares of Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 price target for the company in a research report on Wednesday, April 29th. Three analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $176.00.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.